Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose exploration of disodium phosphopropofol for anesthesia induction in elderly knee replacement patients
ChiCTR2200067109Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Jan 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fospropofol disodium in orthopedic diseases (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Satisfactory induction of anesthesia. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
orthopedic diseases
Beyond the preview
Go deeper on ChiCTR2200067109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067109.